John A. Kollins serves as Executive at Transcept Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, John A. Kollins has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 6, 2023 involved transacting 305,911 shares valued at $278.4K.
John A. Kollins currently holds 4,161 shares of Transcept Pharmaceuticals Inc (TSPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John A. Kollins has been a net neutral trader of TSPT stock. They have purchased $0 and sold $0 worth of shares.
John A. Kollins's most recent insider trade was on Jun 6, 2023, when they sold 305,911 shares at $0.91 per share.
Get notified when new Form 4 filings are submitted
| $21.59 |
| Discretionary |